Author Question: Non-persistent pesticides like organophosphates and carbamates A) will be far less likely to ... (Read 13 times)

fox

  • Hero Member
  • *****
  • Posts: 540
Non-persistent pesticides like organophosphates and carbamates
 
  A) will be far less likely to cause biomagnification and bioamplification than persistent pesticides.
  B) will produce fatal toxic effects in all producers and low-level consumers that are exposed.
  C) target only the pest species; there are no non-target kills.
  D) produce resistance in pest predators but not in the pests themselves.

Question 2

In the processes of pesticide biomagnification and bioaccumulation impacting a food chain
 
  A) the pesticide has to be non-biodegradable (persistent) for the processes to occur.
  B) the greatest levels of mortality are in the producers and first level consumers.
  C) the concentrations may not be fatal if the top consumers are very small.
  D) consumers at the top of the food chain will develop rapid pesticide resistance.



cegalasso

  • Sr. Member
  • ****
  • Posts: 295
Answer to Question 1

A

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

For a complete list of videos, visit our video library